Position in PRTA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,866,321
+$1,259,422 QoQ
Shares Held
905,651
+15.7% QoQ
Ownership
1.76%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 187 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 7%
None 5%
Common Shares in PRTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,868 across 230 Biotechnology names. PRTA ranks #86 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in PRTA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,866,321 | 905,651 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $7,606,899 | 782,603 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $7,403,225 | 775,207 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $7,876,201 | 806,988 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,841,397 | 962,339 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $10,681,454 | 863,148 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $11,977,935 | 864,833 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $14,288,255 | 854,050 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $17,783,092 | 861,584 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $21,372,346 | 862,832 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $31,529,853 | 867,635 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $53,213,089 | 1,102,862 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $78,536,200 | 1,150,208 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $59,745,815 | 1,232,635 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $79,560,183 | 1,320,501 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $89,969,158 | 1,483,905 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $42,537,341 | 1,566,753 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $55,043,554 | 1,505,156 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $74,027,727 | 1,498,537 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $112,518,327 | 1,579,648 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $81,503,409 | 1,585,361 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $39,667,042 | 1,579,102 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $20,873,007 | 1,737,969 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $17,632,350 | 1,765,000 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $18,847,152 | 1,801,831 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $19,553,180 | 1,827,400 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||